Main
>
ONCOLOGY (**)
>
Breast Cancer>HER2+ ***
>
Adjuvant TREAT.
>
Co: USA. P. Neratinib
>
(*) AR Approval Date: 2019. 09.04
(*) AR Approval Date: 2019. 09.04's products
This section has no products